slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,539
Current window 90,661-90,690
Pages 3,685
Rows per page 30
Component
90,661-90,690 of 110,539
16
Includes both actual and normalized net spread bridge charts.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
19
Includes three donut charts showing AUM/Dry Powder totals and strategy-specific breakdowns.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
25
Contains multiple tables summarizing financial performance metrics for 3Q'23 and YTD'23.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · Action1 hit
38
Apollo Global Management | Results Presentation Deck | 41 slidesApollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · Action1 hit
39
This is a standard disclosure/definitions slide common in financial investor presentations.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · Action1 hit
08
The slide uses a process-oriented flow diagram to explain the mechanism of action for a combination therapy.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
10
The slide highlights the mechanism of action and key therapeutic benefits of the drug candidate.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Product1 hit
11
The slide outlines the study design for cohorts E through K in Part 3 of the trial.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Product1 hit
12
Data shows consistent efficacy across different patient subgroups.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Product1 hit
13
The slide displays longitudinal clinical trial data for a drug candidate (Imdusiran) across various dosing regimens (Cohorts E, F, I, J, G, K).Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Product1 hit
14
Clinical trial data showing individual patient responses over time, including two cases of NA retreatment.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Product1 hit
15
Data presented at EASL 2022. Shows longitudinal patient data for patients 42, 43, and 48.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Product1 hit
16
The slide uses a bulleted list to present key safety outcomes, including lack of serious adverse events and stability of laboratory markers.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
18
The slide uses a timeline-based process diagram to illustrate the clinical trial randomization and treatment arms.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
03
The slide uses a circular process flow diagram to illustrate the company's growth strategy.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations Beat · Key Takeaways1 hit
05
The slide uses a timeline-based clinical trial design framework.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations 1 hit
06
The slide outlines a randomized clinical trial structure.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations 1 hit
07
The slide uses a list format to communicate a roadmap of clinical milestones.argenx SE | Results Presentation Deck | 14 slides · argenx
Conference presentation Investor relations Beat · RoadmapLoop · Maturity Curve1 hit
07
The slide uses a waterfall bridge to explain the variance in EBITDA, followed by a detailed EBT reconciliation table.Aston Martin Lagonda | Results Presentation Deck | 18 slides · Aston Martin Lagonda
Conference presentation Investor relations 1 hit
08
The chart uses a standard waterfall bridge format to reconcile EBT to FCF.Aston Martin Lagonda | Results Presentation Deck | 18 slides · Aston Martin Lagonda
Conference presentation Investor relations 1 hit
16
Aston Martin Lagonda | Results Presentation Deck | 18 slidesAston Martin Lagonda | Results Presentation Deck | 18 slides · Aston Martin Lagonda
Conference presentation Investor relations 1 hit
05
Astra | Investor Presentation Deck | 22 slidesAstra | Investor Presentation Deck | 22 slides · Astra
Pitch deck Investor relations Loop · Why Now1 hit
06
The slide uses a vertical matrix structure to categorize business units by purpose, market, and TAM.Astra | Investor Presentation Deck | 22 slides · Astra
Pitch deck Investor relations 1 hit
10
The slide features a high-quality photo of the engine hardware alongside key performance claims.Astra | Investor Presentation Deck | 22 slides · Astra
Pitch deck Investor relations 1 hit
19
The slide emphasizes the portability and operational efficiency of the launch system.Astra | Investor Presentation Deck | 22 slides · Astra
Pitch deck Investor relations 1 hit
20
The slide highlights vertical integration and automated manufacturing as a competitive advantage.Astra | Investor Presentation Deck | 22 slides · Astra
Pitch deck Investor relations 1 hit
21
Uses concentric circles to represent TAM/SAM market sizing.Astra | Investor Presentation Deck | 22 slides · Astra
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
03
Slide 03 of the deck.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
08
Includes two distinct charts: a scatter/error bar plot for Phase 1 and a bar chart for the Canine Model.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
09
The slide demonstrates an inverted U-shaped dose response curve.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit